ATE205216T1 - Platinkomplexe - Google Patents

Platinkomplexe

Info

Publication number
ATE205216T1
ATE205216T1 AT95302629T AT95302629T ATE205216T1 AT E205216 T1 ATE205216 T1 AT E205216T1 AT 95302629 T AT95302629 T AT 95302629T AT 95302629 T AT95302629 T AT 95302629T AT E205216 T1 ATE205216 T1 AT E205216T1
Authority
AT
Austria
Prior art keywords
platinum complexes
cycloalkyl
aryl
alkyl
different
Prior art date
Application number
AT95302629T
Other languages
English (en)
Inventor
Christopher Francis Ja Barnard
Road
Gerald Edward Bossard
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Application granted granted Critical
Publication of ATE205216T1 publication Critical patent/ATE205216T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Photolithography (AREA)
AT95302629T 1994-04-26 1995-04-20 Platinkomplexe ATE205216T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9408218A GB9408218D0 (en) 1994-04-26 1994-04-26 Improvements in platinum complexes

Publications (1)

Publication Number Publication Date
ATE205216T1 true ATE205216T1 (de) 2001-09-15

Family

ID=10754111

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95302629T ATE205216T1 (de) 1994-04-26 1995-04-20 Platinkomplexe

Country Status (12)

Country Link
US (1) US5519155A (de)
EP (1) EP0679656B1 (de)
JP (1) JPH0840892A (de)
AT (1) ATE205216T1 (de)
AU (1) AU692521B2 (de)
CA (1) CA2147567C (de)
DE (1) DE69522490T2 (de)
DK (1) DK0679656T3 (de)
ES (1) ES2162897T3 (de)
GB (1) GB9408218D0 (de)
GR (1) GR3036538T3 (de)
PT (1) PT679656E (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US7138520B2 (en) * 2003-01-13 2006-11-21 Massachusetts Institute Of Technology Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
ES2308451T3 (es) 2004-02-18 2008-12-01 Gpc Biotech Ag Satraplatino para el tratamiento de tumores resistentes o refractarios.
CA2584493A1 (en) 2004-06-18 2006-01-05 Gpc Biotech, Inc. Kinase inhibitors for treating cancers
US20080272022A1 (en) * 2004-07-14 2008-11-06 Gpc Biotech Ag Variable-Dose Packaging System
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
EP2178893A4 (de) * 2007-07-16 2012-09-19 Poniard Pharmaceuticals Inc Orale formulierungen für picoplatin
WO2009032172A2 (en) * 2007-08-31 2009-03-12 Massachusetts Institute Of Technology Platinum compositions as treatment for oct-related cancers
CN102014624A (zh) * 2008-02-08 2011-04-13 帕纳德制药公司 治疗肺癌的吡铂和氨柔比星
WO2010027428A1 (en) * 2008-08-26 2010-03-11 Massachusetts Institute Of Technology Platinum ( iv) complexes for use in dual mode pharmaceutical therapy
WO2010149666A1 (en) 2009-06-22 2010-12-29 Medexis S.A. Methods for treating neoplasia
US20120238488A1 (en) 2009-09-08 2012-09-20 Konstantinos Alevizopoulos Compounds and methods for treating neoplasia
US20130303500A1 (en) 2010-07-30 2013-11-14 Medexis S.A. Compounds and methods for treating neoplasia
WO2012177931A1 (en) 2011-06-21 2012-12-27 Massachusetts Institute Of Technology Compositions and methods for the treatment of cancer
US8729286B2 (en) 2012-05-10 2014-05-20 Massachusetts Institute Of Technology Platinum compounds as treatment for cancers, and related methods, kits, and compositions
WO2014160216A2 (en) 2013-03-13 2014-10-02 Massachusetts Institute Of Technology Dual targeting anticancer agents
WO2014165782A2 (en) 2013-04-05 2014-10-09 Massachusetts Institute Of Technology Compositions, methods, and kits comprising platinum compounds associated with a ligand comprising a targeting moiety

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918878T2 (de) * 1988-02-02 1995-02-23 Johnson Matthey Inc Pt(IV) Komplexe.

Also Published As

Publication number Publication date
DE69522490T2 (de) 2002-05-16
PT679656E (pt) 2001-12-28
AU692521B2 (en) 1998-06-11
AU1766195A (en) 1995-11-02
CA2147567C (en) 2006-01-17
GB9408218D0 (en) 1994-06-15
ES2162897T3 (es) 2002-01-16
EP0679656A1 (de) 1995-11-02
DE69522490D1 (de) 2001-10-11
DK0679656T3 (da) 2001-10-01
GR3036538T3 (en) 2001-12-31
US5519155A (en) 1996-05-21
CA2147567A1 (en) 1995-10-27
EP0679656B1 (de) 2001-09-05
JPH0840892A (ja) 1996-02-13

Similar Documents

Publication Publication Date Title
ATE205216T1 (de) Platinkomplexe
TR200000896T2 (tr) Amidokarboksilik asit türevleri.
NO890426D0 (no) Platina(iv)komplekser.
Korytowski et al. Mechanism of dismutation of superoxide produced during autoxidation of melanin pigments
TR200000482T2 (tr) N-Aroilfenilalanin türevleri.
NO960569L (no) Forbedringer i platina-komplekser
DE59108419D1 (de) Dicarbonsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide
DK165109C (da) 4-anilino-cyklopentaoedaapyrimidinderivater samt farmaceutiske midler indeholdende saadanne
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
TR199700354A2 (xx) Karbohidrat t�revleri.
DE58903671D1 (de) Schwefelhaltige oximether und diese enthaltende fungizide.
ATE266670T1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification